Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Georgieva

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Hazardous Materials|December 17, 2011
Bi-component semiconductor oxide photoanodes for the photoelectrocatalytic oxidation of organic solutes and vapours: a short review with emphasis to TiO2-WO3 photoanodesJ Georgieva, E Valova, S Armyanov, et al.
The British Journal of Dermatology|December 17, 2003
Bodybuilder oleomaJ Georgieva, C Assaf, M Steinhoff, et al.
Neuroscience|June 11, 1998
Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effectJ Sandin, I Nylander, J Georgieva, et al.
Gene Therapy|June 6, 1998
Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I studyY Sun, K Jurgovsky, P Möller, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Hazardous Materials|December 17, 2011
Bi-component semiconductor oxide photoanodes for the photoelectrocatalytic oxidation of organic solutes and vapours: a short review with emphasis to TiO2-WO3 photoanodesJ Georgieva, E Valova, S Armyanov, et al.
The British Journal of Dermatology|December 17, 2003
Bodybuilder oleomaJ Georgieva, C Assaf, M Steinhoff, et al.
Neuroscience|June 11, 1998
Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effectJ Sandin, I Nylander, J Georgieva, et al.
Gene Therapy|June 6, 1998
Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I studyY Sun, K Jurgovsky, P Möller, et al.
Pageof 3